In Silico Pharmacology, Год журнала: 2024, Номер 12(2)
Опубликована: Ноя. 2, 2024
Язык: Английский
In Silico Pharmacology, Год журнала: 2024, Номер 12(2)
Опубликована: Ноя. 2, 2024
Язык: Английский
Medicinal Chemistry Research, Год журнала: 2024, Номер 33(4), С. 620 - 634
Опубликована: Март 5, 2024
Abstract
Isatin
(indol-2,3-dione),
a
secondary
metabolite
of
tryptophan,
has
been
used
as
the
core
structure
to
design
several
compounds
that
have
tested
and
identified
potent
inhibitors
apoptosis,
potential
antitumor
agents,
anticonvulsants,
antiviral
agents.
In
this
work,
analogs
isatin
hybrids
synthesized
characterized,
their
activities
were
established
both
Aurora
A
kinase
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
spike/host
angiotensin-converting
enzyme
II
(ACE2)
interactions.
Amongst
hybrids,
6a
,
6f
6g
6m
exhibited
inhibitory
(with
IC
50
values
<
5
$$\mu$$
Язык: Английский
Процитировано
5The Microbe, Год журнала: 2024, Номер 3, С. 100059 - 100059
Опубликована: Март 23, 2024
In silico binding studies were conducted on the known plant-derived polyphenolic tetrameric stilbenoids, (–)-hopeaphenol (1), vaticanol B (2) and vatalbinoside A (3) their monomeric derivative resveratrol (8), identified from several plant species. The natural products 1–3 had been previously evaluated against SARS-CoV-2 protein targets responsible for viral transmission infection. two isomeric compounds displayed a high affinity blocking of spike with human angiotensin-converting enzyme 2 (ACE2). Molecular docking molecular dynamics simulations have used to attempt explain spike/ACE2 complex. hydrophobic properties respective target sites computed compared physicochemical each compound toward site. ADMET/DMPK profiles also demonstrate potential fragments as lead antiviral discovery. These results reported here support experimental data obtained date clearly identify stilbenoid structure class one worthy future during chemical biology and/or drug discovery efforts.
Язык: Английский
Процитировано
5Medicinal Chemistry Research, Год журнала: 2025, Номер unknown
Опубликована: Фев. 23, 2025
Язык: Английский
Процитировано
0Journal of Organometallic Chemistry, Год журнала: 2024, Номер 1013, С. 123184 - 123184
Опубликована: Май 17, 2024
Язык: Английский
Процитировано
2The Microbe, Год журнала: 2024, Номер 4, С. 100143 - 100143
Опубликована: Авг. 15, 2024
The emergence of the severe acute respiratory syndrome 2 (SARS-CoV-2) as a global threat has driven urgent need for identification bioactive molecules capable controlling or completely eradicating this virus. Our group been investigating isatin hybrids that block binding human angiotensin-converting enzyme (ACE2) and viral spike protein. This work describes synthesis biological evaluation two derivatives (indol-2,3-dione) based on computational approach. Isatin, secondary metabolite tryptophan, used core structure is versatile favorable precursor privileged scaffold against complex. new compound scaffolds AVS-01 AVS-02 were designed by modifications at C-3 N-1 positions, respectively, according to various reagents available in our lab. Molecular docking compounds was explore their interactions with target protein shown article showed quite distinct glide scores (GScore = −3.657 −4.534 AVS-02, respectively). Several analogs synthesized tested quest find plausible further synthesis. While inhibition spike/ACE2 an IC50 value 8.8 µM, reference hopeaphenol inhibited interaction 0.3 µM. Compound rather no SARS-CoV-2 spike/host ACE2 > 32 An estimation free energy (ΔGbind), solvation (ΔGsolv) MM-GBSA calculations carried out re-evaluate affinity gain insights into observed activity non-activity. calculation ΔGbind −35.91 kcal/mol and-25.32 ΔGsolv 25.56 16.92 respectively. leads conclusion position indole-2,3-dione moiety favors blockage compared position. Analysis GScores, per-residue energies, energies van der Waals should favor towards
Язык: Английский
Процитировано
1Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Май 22, 2024
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Июнь 21, 2024
Язык: Английский
Процитировано
0In Silico Pharmacology, Год журнала: 2024, Номер 12(2)
Опубликована: Ноя. 2, 2024
Язык: Английский
Процитировано
0